Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Transplantation Proceedings
|
June 1, 1995
Evidence that the degeneration of heart valve grafts is immunologic
N Zavazava, A Simon, W Müller-Ruchholtz
Transplantation
|
April 1, 1991
Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA
N Zavazava, R Hausmann, W Müller-Ruchholtz
Tissue Antigens
|
July 1, 1993
Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients
N Zavazava, H Böttcher, W M Ruchholtz
Transplantation Proceedings
|
August 1, 1990
Affinity-purified HLA class I molecules specifically inhibit a human CTL line in vitro
R Hausmann, N Zavazava, W Müller-Ruchholtz
Journal of Clinical Laboratory Analysis
|
January 1, 1990
Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor
N Zavazava, G Leimenstoll, W Müller-Ruchholtz
Transplantation Proceedings
|
August 1, 1991
Interaction of purified HLA class I molecules with alloreactive CTL
R Hausmann, N Zavazava, W Müller-Ruchholtz
Journal of Immunogenetics
|
December 1, 1990
Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals
N Zavazava, E Westphal, W Müller-Ruchholtz
Transplantation Proceedings
|
December 1, 1995
Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage
D Abendroth, M Storck, B Techt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1992
Clinical relevance of soluble HLA and interaction of papain derived class I molecules with alloreactive CTL
N Zavazava, R Hausmann, E Kraatz, et al.
Journal of Clinical Laboratory Analysis
|
January 1, 1994
Soluble MHC class I molecules in human body fluids
N Zavazava, B Wobst, R Ferstl, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Transplantation Proceedings
|
June 1, 1995
Evidence that the degeneration of heart valve grafts is immunologic
N Zavazava, A Simon, W Müller-Ruchholtz
Transplantation
|
April 1, 1991
Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA
N Zavazava, R Hausmann, W Müller-Ruchholtz
Tissue Antigens
|
July 1, 1993
Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients
N Zavazava, H Böttcher, W M Ruchholtz
Transplantation Proceedings
|
August 1, 1990
Affinity-purified HLA class I molecules specifically inhibit a human CTL line in vitro
R Hausmann, N Zavazava, W Müller-Ruchholtz
Journal of Clinical Laboratory Analysis
|
January 1, 1990
Measurement of soluble MHC class I molecules in renal graft patients: a noninvasive allograft monitor
N Zavazava, G Leimenstoll, W Müller-Ruchholtz
Transplantation Proceedings
|
August 1, 1991
Interaction of purified HLA class I molecules with alloreactive CTL
R Hausmann, N Zavazava, W Müller-Ruchholtz
Journal of Immunogenetics
|
December 1, 1990
Characterization of soluble HLA molecules in sweat and quantitative HLA differences in serum of healthy individuals
N Zavazava, E Westphal, W Müller-Ruchholtz
Transplantation Proceedings
|
December 1, 1995
Analysis of the rejection markers tumor necrosis factor, ICAM-1, neopterin, interleukin-10, and soluble HLA in simultaneous pancreas and kidney transplantation with bladder drainage
D Abendroth, M Storck, B Techt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1992
Clinical relevance of soluble HLA and interaction of papain derived class I molecules with alloreactive CTL
N Zavazava, R Hausmann, E Kraatz, et al.
Journal of Clinical Laboratory Analysis
|
January 1, 1994
Soluble MHC class I molecules in human body fluids
N Zavazava, B Wobst, R Ferstl, et al.
Page
of 6